| Literature DB >> 17060667 |
Bill T Ameredes, William J Calhoun.
Abstract
Is there scientific evidence to support the replacement of the beta-agonist racemic albuterol with levalbuterol--that is, (R)-albuterol? The argument presented further refines the question as "Do we wish to continue to treat asthma with a mixture of albuterol, of which half is an agent with no known benefit--that is, (S)-albuterol--and which may exacerbate the disease?"Entities:
Mesh：
Substances：
Year: 2006 PMID： 17060667 DOI： 10.1164/rccm.2606001
Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405